This site contains promotional content intended for Healthcare Professionals in Ireland and other relevant decision makers | Not a HCP? Visit our Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Sign In
Don’t have an account?
  • Products
  • Therapy Area
  • Resources
  • Events & Webinars
  • Learning Zone
  • Podcasts
Bayer Logo
BAYERPROYour Resource Portal
  • Cardiology
  • Beyonttra®▼ (acoramidis)
  • Oncology
  • Nubeqa® (darolutamide)
  • Xofigo®▼ (radium-223 dichloride)
  • Women's Health
  • Jaydess® ▼ (13.5mg levonorgestrel)
  • Kyleena® (19.5mg levonorgestrel)
  • Mirena® (52mg levonorgestrel)
  • Qlaira® (estradiol valerate/dienogest)
  • Ophthalmology
  • Eylea® (aflibercept) 8mg
Products
  • Cardiology
  • Oncology
  • Ophthalmology
  • Women's Health
  • Cardiology Resources
  • Oncology Resources
  • Ophthalmology Resources
  • Women's Health Resources
  • Bayer Events & On Demand Webinars
  • Cardiology Events & On Demand Webinar
  • Oncology Events & On Demand Webinars
  • Ophthalmology Events & On Demand Webinars
  • Women's Health Events & On Demand Webinars
  • Cardiology Learning Zone
  • Oncology Learning Zone
  • Ophthalmology Learning Zone
  • Women's Health Learning Zone
  • Cardiology Podcasts
  • Oncology Podcasts
  • Ophthalmology Podcasts
closesearch
Recent Searches
    BayerPRO IRE Above Brand Header

    Products

    About Beyonttra®▼ (acoramidis)
    Learn more about Beyonttra® (acoramidis).
    Beyonttra Prescribing Information
    PP-BEY-IE-0031-1, November 2025

    Events & On Demand Webinars

    View more
    ATTR-CM Expert Series
    Join us as Prof Fontana takes us through the clinical data, patient cases and other aspects related to ATTR-CM. | Beyonttra®▼ (acoramidis)
    Beyonttra®▼ (acoramidis) Prescribing Information
    PP-PF-CAR-IE-0015-1, March 2026
    ATTR-CM Nurse Expert Series
    This short series focuses on clinical and dietary aspects of ATTR-CM management. | Beyonttra®▼ (acoramidis)
    Beyonttra®▼ (acoramidis) Prescribing Information
    PP-PF-CAR-IE-0016-1, March 2026
    Expert Insights into ATTR-CM
    This series explores the complexities of ATTR-CM. Join us in a discussion on diagnosis, treatment, and the importance of a multidisciplin...
    Beyonttra®▼ (acoramidis) Prescribing Information
    PP-PF-CAR-IE-0017-1, April 2026
    ATTR-CM Masterclass Series
    This comprehensive series is designed to provide healthcare professionals with an in-depth understanding of transthyretin amyloid cardiom...
    Beyonttra®▼ (acoramidis) Prescribing Information
    PP-PF-CAR-IE-0018-1, April 2026